CADEDDU DESSALVI, CHRISTIAN
 Distribuzione geografica
Continente #
EU - Europa 309.411
NA - Nord America 10.804
AS - Asia 4.566
AF - Africa 1.051
SA - Sud America 758
OC - Oceania 53
Continente sconosciuto - Info sul continente non disponibili 8
Totale 326.651
Nazione #
IT - Italia 306.613
US - Stati Uniti d'America 10.614
SG - Singapore 1.708
CN - Cina 1.550
ZA - Sudafrica 801
UA - Ucraina 761
SE - Svezia 689
BR - Brasile 645
GB - Regno Unito 341
DE - Germania 306
VN - Vietnam 302
IN - India 272
FI - Finlandia 224
BD - Bangladesh 138
FR - Francia 121
CA - Canada 117
KR - Corea 90
HK - Hong Kong 68
KE - Kenya 59
NL - Olanda 59
BE - Belgio 56
TR - Turchia 46
PK - Pakistan 44
ZM - Zambia 44
SA - Arabia Saudita 42
AT - Austria 39
PL - Polonia 39
RU - Federazione Russa 39
ID - Indonesia 37
AR - Argentina 35
ES - Italia 35
MX - Messico 31
JP - Giappone 27
UG - Uganda 27
PH - Filippine 25
AU - Australia 24
NP - Nepal 24
AE - Emirati Arabi Uniti 22
EC - Ecuador 19
IR - Iran 19
MY - Malesia 17
IQ - Iraq 16
LK - Sri Lanka 15
MA - Marocco 15
GH - Ghana 14
UZ - Uzbekistan 14
CL - Cile 13
NG - Nigeria 13
EG - Egitto 12
FJ - Figi 12
KW - Kuwait 12
TN - Tunisia 12
CO - Colombia 11
KH - Cambogia 11
TZ - Tanzania 11
PE - Perù 10
PY - Paraguay 10
MW - Malawi 9
RO - Romania 9
TW - Taiwan 9
ZW - Zimbabwe 9
BG - Bulgaria 8
CU - Cuba 8
IE - Irlanda 8
NZ - Nuova Zelanda 8
PT - Portogallo 8
TH - Thailandia 8
EU - Europa 7
IL - Israele 7
LT - Lituania 7
NO - Norvegia 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
JO - Giordania 6
LC - Santa Lucia 6
OM - Oman 6
CH - Svizzera 5
CY - Cipro 5
DZ - Algeria 5
JM - Giamaica 5
KZ - Kazakistan 5
LV - Lettonia 5
PG - Papua Nuova Guinea 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
ET - Etiopia 4
GR - Grecia 4
HN - Honduras 4
HR - Croazia 4
KG - Kirghizistan 4
PR - Porto Rico 4
SB - Salomone, isole 4
SI - Slovenia 4
BH - Bahrain 3
BO - Bolivia 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
LS - Lesotho 3
MM - Myanmar 3
MU - Mauritius 3
Totale 326.610
Città #
Cagliari 210.874
Uta 95.140
Fairfield 1.109
Woodbridge 947
Ashburn 933
Dallas 728
Singapore 695
Houston 649
Chandler 619
Ann Arbor 564
Boardman 514
Wilmington 486
Nyköping 452
Seattle 430
Jacksonville 402
Cambridge 391
Beijing 334
Dearborn 246
Johannesburg 210
Santa Clara 165
Los Angeles 159
Nanjing 159
Boston 125
Hefei 114
Buffalo 90
Dong Ket 90
Shanghai 89
Helsinki 88
New York 85
Seoul 85
Ho Chi Minh City 84
Cape Town 74
Pretoria 70
San Diego 68
The Dalles 67
Hong Kong 66
São Paulo 58
Toronto 57
London 53
Guangzhou 52
Nanchang 49
Redwood City 49
Tianjin 47
Shenyang 45
Milan 43
Hanoi 42
Lusaka 42
Munich 42
Chicago 37
Hebei 37
Council Bluffs 33
Durban 33
Atlanta 32
Brussels 32
Changsha 31
Phoenix 31
Chennai 29
Amsterdam 27
Brooklyn 27
Nairobi 27
Orange 27
Dhaka 25
Jiaxing 25
Redondo Beach 25
Warsaw 25
Montreal 24
Nuremberg 24
Jinan 23
Tokyo 23
Denver 22
Mountain View 22
Belo Horizonte 21
Frankfurt am Main 21
Norwalk 20
Rome 20
Zhengzhou 20
Auburn Hills 19
Columbus 18
Rio de Janeiro 18
Sassari 18
Mumbai 17
Washington 17
Kunming 16
Turku 16
Vienna 16
Ankara 15
Quito 15
Stockholm 15
Verona 15
Kampala 14
Orem 14
Wuhan 14
Accra 13
Düsseldorf 13
Manchester 13
Paris 12
Pune 12
Augusta 11
Dar es Salaam 11
Phnom Penh 11
Totale 319.076
Nome #
Non-invasive estimation of stroke volume during exercise from oxygen in heart failure patients 75.086
Management of cancer patients at high and very-high risk of cardiotoxicity: Main questions and answers 12.861
Early ischemia identification employing 2D speckle tracking selective layers analysis during dobutamine stress echocardiography 4.339
Metabolomic approach to profile functional and metabolic changes in heart failure 4.203
Pathophysiology of cardiotoxicity induced by nonanthracycline chemotherapy 4.143
Distinctive metabolomic fingerprint in scleroderma patients with pulmonary arterial hypertension 3.878
Timing of the negative effects of trastuzumab on cardiac mechanics after anthracycline chemotherapy 3.549
Blood metabolomic fingerprint is distinct in healthy coronary and in stenosing or microvascular ischemic heart disease 3.508
Contractile reserve in systemic sclerosis patients as a major predictor of global cardiac impairment and exercise tolerance 3.507
Heart rate variability shows different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 3.433
Metabolomics Profile of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 3.354
Effects of metformin and exercise training, alone or in combination, on cardiac function in individuals with insulin resistance 3.304
Metabolomic fingerprint of coronary blood in STEMI patients depends on the ischemic time and inflammatory state 3.080
Effects of a mini-trampoline rebounding exercise program on functional parameters, body composition and quality of life in overweight women 3.013
Metabolomics and heart failure: a new and promising scientific approach 2.960
Coronary Artery Disease 2.907
Altered transmural contractility in postmenopausal women affected by cardiac syndrome X 2.798
Long-term Protective Effects of the Angiotensin Receptor Blocker Telmisartan on Epirubicin-induced Inflammation, Oxidative Stress and Myocardial Dysfunction 2.793
Modelling chemotherapy-induced cardiotoxicity by human pluripotent stem cells 2.729
Cardioprotection by gene therapy: review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology 2.713
Sex-related differential susceptibility to ponatinib cardiotoxicity and differential modulation of the Notch1 signalling pathway in a murine model 2.706
Metabolomic approach to redox and nitrosative reactions in cardiovascular diseases 2.674
Metabolomics, a promising approach to translational research in cardiology 2.654
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 2.507
Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection 2.475
Effects of Metformin Treatment on Myocardial and Endothelial Function in Insulin Resistance Patients: A Metabolomic Study. 2.369
Antioxidant approach as a cardioprotective strategy in chemotherapy-induced cardiotoxicity 2.359
A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology 2.280
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 2.253
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 2.236
Women-specific predictors of cardiovascular disease risk - new paradigms 2.207
Metabolomic Analysis of Patients with Chronic Myeloid Leukemia and Cardiovascular Adverse Events after Treatment with Tyrosine Kinase Inhibitors 2.191
null 2.190
Ponatinib Induces Vascular Toxicity through the Notch-1 Signaling Pathway 2.185
Study on the correlation among total burden of nonmotor symptoms and cardiovascular dysmodulation in Parkinson’s disease patients 2.180
Inverted Takotsubo cardiomyopathy induced by dobutamine stress echocardiography with atypical presentation 2.147
Effects of an aquatic-based exercise program to improve cardiometabolic profile, quality of life, and physical activity levels in men with type 2 diabetes mellitus 2.145
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world 2.133
Autonomic imbalance in Parkinson's disease patients with or without LRRK2 gene mutations 2.113
Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects 2.086
Antineoplastic drug-induced cardiotoxicity: A redox perspective 2.073
The need of a gender-corrected evidence based medicine 2.060
Gender differences in the development of cardiac complications: A multicentre study in a large cohort of thalassaemia major patients to optimize the timing of cardiac follow-up 1.984
Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogens 1.949
Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention 1.941
Metabolic pathways in heart failure correlate with impaired longitudinal global strain rate 1.907
Ultrasound examination for the detection of simulated periapical bone lesions in bovine mandibles: an ex vivo study 1.893
Current views on anthracycline cardiotoxicity 1.885
A novel desmoplakin mutation associated with left dominant arrhythmogenic cardiomyopathy and cutaneous phenotype 1.878
Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry 1.870
Arterial hypertension in the female world: Pathophysiology and therapy 1.851
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 1.829
Bridging the mortality gap: A new challenge in percutaneous coronary intervention for patients with cancer 1.824
Early right ventricular dysfunction in highly selected (totally free from cardiovascular risk factors and other comorbidities) human immunodeficiency virus patients: A pilot study with advanced echocardiography 1.792
Multimodality imaging diagnosis of multiple ventricular thrombosis and massive stroke after gemcitabine and cisplatin chemotherapy for Urothelial Cancer 1.769
Effects of metformin and exercise training, alone or in association, on cardio-pulmonary performance and quality of life in insulin resistance patients 1.758
Preventing antiblastic drug-related cardiomyopathy: Old and new therapeutic strategies 1.742
Gender differences in cardiology: is it time for new guidelines? 1.742
Metabolomic perspectives in antiblastic cardiotoxicity and cardioprotection 1.708
Early diagnosis, clinical management, and follow-up of cardiovascular events with ponatinib 1.672
L’analisi metabolomica delle vie metaboliche nei pazienti affetti da scompenso cardiaco correla con lo strain rate longitudinale 1.671
A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: An opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology 1.654
Persistence, up to 18 months of follow-up, of epirubicin-induced myocardial dysfunction detected early by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.650
Role of biomarkers in monitoring antiblastic cardiotoxicity 1.616
Evaluation of left atrial appendage function and thrombi in patients with atrial fibrillation: from transthoracic to real time 3D transesophageal echocardiography 1.563
High prevalence of interatrial septal aneurysm in young adults who were born preterm 1.562
Subclinical contractility impairment in HIV-infected patients varies according to class of antiretroviral drugs 1.549
Subclinical contractility impairment in HIV-infected patients: Dependence on the class of antiretroviral drugs 1.545
Vascular damage-Coronary artery disease 1.520
The different role of sex hormones on female cardiovascular physiology and function: not only oestrogens 1.498
null 1.489
Cardioprotective effect of telmisartan in cancer patients treated with telmisartan 1.486
Diastolic Function in Systemic Sclerosis Patients: A Neglected Issue? 1.484
null 1.471
Early epirubicin-induced myocardial dysfunction revealed by serial tissue Doppler echocardiography: correlation with inflammatory and oxidative stress markers 1.464
Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC) 1.463
Trastuzumab-induced early cardiac dysfunction assessed by speckle tracking echocardiography: correlation with chronic inflammation and oxidative stress markers 1.444
Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: Role of echocardiography 1.435
Antiinflammatory therapy with canakinumab for atherosclerotic disease 1.430
Early Ventricular Dysfunction in Type II Diabetes: Role of Metabolic Unbalance 1.387
Altered transmural contractility in women affected by cardiac X syndrome 1.378
Metabolomics: a new era in cardiology? 1.321
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry 1.309
Time-to-balloon dependence of coronary flow velocity reserve after primary angioplasty in patients with anterior acute myocardial infarction 1.290
Protective effects of the angiotensin II receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress, and early ventricular impairment 1.288
Early impairment of contractility reserve in patients with insulin resistance in comparison with healthy subjects 1.273
Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: cardiovascular magnetic resonance and nuclear cardiology 1.270
Cardioprotective effect of telmisartan in cancer patients treated with epirubicin. 1.267
Consensus: Screening e terapia della cardiopatia ischemica nel paziente diabetico 1.236
null 1.234
Long-term, up to 18 months, protective effects of the angiotensin II receptor blocker telmisartan on Epirubin-induced inflammation and oxidative stress assessed by serial strain rate 1.182
Significant QT interval prolongation and long QT in young adult ex-preterm newborns with extremely low birth weight 1.169
Late persistence of elevated levels of reactive oxygen species is associated with a progressive impairment of systolic function after treatment with epirubicin 1.156
Relationship between high values of HOMA-IR and cardiovascular response to metformin 1.125
Mortality for pancreatic cancer among aluminium smelter workers in Sardinia, Italy 1.106
null 1.054
Trastuzumab induced-early cardiac disfunction assessed with TDI: correlation with biological markers of chronic inflammation and oxidative stress. 1.028
Different cardiovascular modulation in Parkinson's disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype 1.018
Preliminary data on a cardioprotective effect of telmisartan in cancer patients treated with epirubicin 960
null 944
Totale 285.364
Categoria #
all - tutte 389.377
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 389.377


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123.530 0 0 0 0 0 6.372 4.361 3.509 1.452 2.874 2.835 2.127
2021/202211.512 1.423 722 575 1.132 887 739 551 701 1.216 1.068 1.201 1.297
2022/202316.778 1.663 2.553 2.364 1.487 1.426 1.398 717 1.151 1.126 885 1.277 731
2023/202419.141 981 726 751 1.407 1.973 3.243 3.007 1.263 1.173 1.249 1.714 1.654
2024/2025130.294 9.143 11.685 81.569 18.133 2.082 3.510 2.373 226 443 270 360 500
2025/20265.450 648 513 1.387 975 968 959 0 0 0 0 0 0
Totale 327.354